Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 86 for “"ca125"”.

  1. Characterizing the Tandem Repeat Region of Ovarian Cancer Biomarker CA125

    … gynecologic cancer mortality, with the biomarker CA125 playing a crucial role in its clinical management. However, the molecular structure of CA125, a peptide epitope located within the mucin protein MUC16, remains incompletely understood, limiting the clinical utility of current CA125-based …

    ku Repository record for Characterizing the Tandem Repeat Region of Ovarian Cancer Biomarker CA125 (opens in a new tab)

  2. Surface Plasmon Resonance Method Optimization and Instrumental Variability Investigation: Mapping Antibody Recognition of CA125

    … at a localized stage. Cancer Antigen 125 (CA125) has been the primary biomarker used to monitor ovarian cancer for decades, and serum levels have been shown to rise on average three years before diagnosis with ovarian cancer. However, several limitations prevent CA125 from being useful as a …

    ku Repository record for Surface Plasmon Resonance Method Optimization and Instrumental Variability Investigation: Mapping Antibody Recognition of CA125 (opens in a new tab)

  3. Mechanism and clinical significance of elevated CA125 levels in the sera of pregnant women

    本文データは平成22年度国立国会図書館の学位論文(博士)のデジタル化実施により作成された画像ファイルを基にpdf変換したものである

    kyoto Repository record for Mechanism and clinical significance of elevated CA125 levels in the sera of pregnant women (opens in a new tab)

  4. Συσχέτιση του προεγχειρητικού Ca125 και Tag72-4 με την επιβίωση σε ασθενείς με καρκίνο ενδομητρίου

    … της προεγχειρητικής τιμής των καρκινικών δεικτών Ca125 και Tag72-4 με την επιβίωση σε ασθενείς με καρκίνο του Ενδομητρίου. Μέθοδος: Αναδρομική μελέτη 282 ασθενών (μέση ηλικία 62.3, sd 10.5 ετών) με πρωτοπαθή Καρκίνο Ενδομητρίου. Αποκλείστηκαν παθήσεις που σχετίζονται με μεταβολές των καρκινικών …

    athens Repository record for Συσχέτιση του προεγχειρητικού Ca125 και Tag72-4 με την επιβίωση σε ασθενείς με καρκίνο ενδομητρίου (opens in a new tab)

  5. Development and evaluation of Keratin 7/19 serum test for ovarian cancer in combination with biomarkers CA125 and HE4

    … combination with already established biomarkers CA125 and HE4 could increase the sensitivity of cancer detection while maintaining high specificity. Different antibody combinations directed against keratin 7/19 were evaluated as possible candidates for an ovarian cancer serum test based on a …

    chalmers Repository record for Development and evaluation of Keratin 7/19 serum test for ovarian cancer in combination with biomarkers CA125 and HE4 (opens in a new tab)

  6. Development and preclinical evaluation of theranostic agents targeting muc16/ca125 and nectin-4 expression in breast, ovarian and pancreatic cancers

    Small protein domain-based affinity reagents and full-length antibodies that recognize cancer biomarkers can be used as vehicles to deliver contrast agents (imaging) or cytotoxic payloads (therapy) to the site of tumours. The development of theranostic agents allows for both therapy as well as …

    sask Repository record for Development and preclinical evaluation of theranostic agents targeting muc16/ca125 and nectin-4 expression in breast, ovarian and pancreatic cancers (opens in a new tab)

  7. MUC16/CA125 Regulation by the Proinflammatory Cytokines TNF α and IFNγ and the PPARγ Agonist Rosiglitazone in Breast and Ovarian Cancers

    … weight transmembrane mucin (TM) carrying the CA125 epitope, a well-known molecular marker for human cancers. TMs are restricted to the apical surface of normal epithelia. TMs not only are over-expressed, but also lose polarized distribution in cancers. Similar to other TMs, MUC16 is …

    rice Repository record for MUC16/CA125 Regulation by the Proinflammatory Cytokines TNF α and IFNγ and the PPARγ Agonist Rosiglitazone in Breast and Ovarian Cancers (opens in a new tab)

  8. Επαλήθευση μεθόδου και κλινική αξιολόγηση του νέου βιοδείκτη ΗΕ4 για τον καρκίνο των ωοθηκών

    … των ωοθηκών. Η μέτρηση του σε συνδυασμό με το CA125 στον αλγόριθμο ROMA πρόσφατα εγκρίθηκε από το FDAγια να προσδιοριστεί η πιθανότητα εύρεσης κακοήθειας σε χειρουργική επέμβαση σε γυναίκες που βρίσκονται πριν ή μετά την εμμηνόπαυση και παρουσιάζουν μια ωοθηκική μάζα. Σκοπός της παρούσας …

    athens Repository record for Επαλήθευση μεθόδου και κλινική αξιολόγηση του νέου βιοδείκτη ΗΕ4 για τον καρκίνο των ωοθηκών (opens in a new tab)

  9. Individualizing Ovarian Cancer Surveillance: Discovery and Validation of Serological Personalized Biomarkers of Recurrence Using Multiplex Proteomics Technologies

    … The classical ovarian cancer biomarker, CA125, is controversial for monitoring recurrence as initiating second-line therapy sooner based on CA125 does not impact survival. Furthermore, CA125 is non-elevated at diagnosis in 10-20% of advanced ovarian cancer cases in general, leaving this …

    toronto-retro Repository record for Individualizing Ovarian Cancer Surveillance: Discovery and Validation of Serological Personalized Biomarkers of Recurrence Using Multiplex Proteomics Technologies (opens in a new tab)

  10. MICRO/NANO PARTICLE LABELED ANTIBODY/APTAMER BASED IMMUNOASSAYS FOR THE DETECTION OF OVARIAN CANCER USING LASER BASED SPECTROSCOPIC TECHNIQUES

    … user-friendly. Currently, cancer antigen 125 (CA125), a type of biomarker that can become elevated in a patient’s blood serum, is recommended mostly for clinical tests in the screening of ovarian cancer. However, because of the lack of sensitivity and specificity associated with CA125, the …

    siu-theses Repository record for MICRO/NANO PARTICLE LABELED ANTIBODY/APTAMER BASED IMMUNOASSAYS FOR THE DETECTION OF OVARIAN CANCER USING LASER BASED SPECTROSCOPIC TECHNIQUES (opens in a new tab)

  11. Ο ρόλος της πρωτεΐνης HE4 στην προεγχειρητική διάγνωση των όγκων των ωοθηκών

    … is achieved utilizing either biomarkers (CA125) or transvaginal ultrasonography. However, CA125 shows low specialty concerning ovarian cancer. In this thesis, we study the role of protein HE4, as a biomarker for the differential diagnosis of suspicious ovarian tumors, prior to surgery. …

    greece Repository record for Ο ρόλος της πρωτεΐνης HE4 στην προεγχειρητική διάγνωση των όγκων των ωοθηκών (opens in a new tab)

  12. Biomarkers of disease : concentrations in the serum of women during natural and stimulated ovarian cycles and during early pregnancy

    … measured were prostate specific antigen (PSA), CA125, CA15‐3, CA72‐4, and pregnancy associated plasma protein‐a (PAPP‐A). The patterns of change during natural and stimulated ovarian cycles and early pregnancy were investigated to determine if these biomarkers could reflect normal events …

    edithcowan Repository record for Biomarkers of disease : concentrations in the serum of women during natural and stimulated ovarian cycles and during early pregnancy (opens in a new tab)

  13. Ovarian cancer. Biomarkers, surgical outcome and survival.

    … diagnosis have been sought for decades. To date, CA125 and HE4 are the only biomarkers in clinical use. Both lack sensitivity and specificity for early-stage EOC. The standard treatment for EOC is primary surgery with adjuvant chemotherapy. Centralisation of ovarian cancer care to high-volume …

    lund Repository record for Ovarian cancer. Biomarkers, surgical outcome and survival. (opens in a new tab) Download PDF for Ovarian cancer. Biomarkers, surgical outcome and survival. (opens in a new tab)

  14. Programmable bio-nano-chip immunosensor for multiplexed detection of ovarian cancer biomarkers

    … the p-BNC was adapted for Cancer Antigen 125 (CA125) quantitation, the current FDA standard, with prominent implications in novel early detection and screening modalities. Antibody pairs binding to distinct epitopes on CA125 were identified and the p-BNC operating variables (incubation times, …

    texas Repository record for Programmable bio-nano-chip immunosensor for multiplexed detection of ovarian cancer biomarkers (opens in a new tab)

  15. N-glycosylated Proteomic Detection of Serum Biomarkers for High-grade Serous Ovarian Carcinoma

    … diagnosis. Cancer antigen 125, or Mucin–16 (CA125) is the current FDA approved biomarker used in the clinic for monitoring response to treatment and cancer recurrence. Although increasing levels of CA125 precede clinical symptoms of cancer recurrence, often “second–look” surgeries reveal …

    toronto-retro Repository record for N-glycosylated Proteomic Detection of Serum Biomarkers for High-grade Serous Ovarian Carcinoma (opens in a new tab)

Page 1 of 5